Functions of Antibodies

Antibodies can impact pathogens in the presence or in the absence of effector cells or effector molecules such as complement, and experiments can often sort out with precision the mechanisms by which an antibody inhibits a pathogen in vitro. In addition, in vivo models, particularly those engineered to knock in or knock out effector cells or effector molecules, are excellent tools for understanding antibody functions. However, it is highly likely that multiple antibody functions occur simultaneously or sequentially in the presence of an infecting organism in vivo. The most critical incentive for measuring antibody functions is to provide a basis for vaccine development and for the development of therapeutic antibodies. In this respect, some functions, such as virus neutralization, serve to inhibit the acquisition of a pathogen or limit its pathogenesis. However, antibodies can also enhance replication or contribute to pathogenesis. This review emphasizes those antibody functions that are potentially beneficial to the host. In addition, this review will focus on the effects of antibodies on organisms themselves, rather than on the toxins the organisms may produce.

[1]  P. Sansonetti,et al.  Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. , 2002, Immunity.

[2]  R. Lawrence,et al.  A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae , 2002, European journal of immunology.

[3]  M. Renedo,et al.  FcγR receptors activate MAP kinase and up‐regulate the cyclooxygenase pathway without increasing arachidonic acid release in monocytic cells , 2002, European journal of immunology.

[4]  A. Capron,et al.  Immunoglobulin E and effector cells in schistosomiasis. , 1994, Science.

[5]  J. Sheehan,et al.  Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. , 1989, Virus research.

[6]  S. Tzipori,et al.  Molecular Cloning and Expression of a Gene EncodingCryptosporidium parvum Glycoproteins gp40 and gp15 , 2000, Infection and Immunity.

[7]  G. Pier,et al.  Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines , 2009, Infection and Immunity.

[8]  J. Rowatt,et al.  Antibody-dependent cellular cytotoxicity of Coxiella burnetii-infected J774 macrophage target cells , 1984, Infection and immunity.

[9]  L. Nencioni,et al.  IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. , 1988, The American review of respiratory disease.

[10]  D. Mosher,et al.  Ail Protein Binds Ninth Type III Fibronectin Repeat (9FNIII) within Central 120-kDa Region of Fibronectin to Facilitate Cell Binding by Yersinia pestis* , 2012, The Journal of Biological Chemistry.

[11]  C. Hahn,et al.  Heteropolymer‐mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications , 2001, Immunological reviews.

[12]  R. Davey,et al.  T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus , 2011, Proceedings of the National Academy of Sciences.

[13]  J. Macaskill,et al.  Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. , 1980, Immunology.

[14]  R. Carter,et al.  Transmission‐blocking antibodies against multiple, non‐variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement‐fixing , 1994, Parasite immunology.

[15]  R. Horton,et al.  Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense , 2013, Front. Immunol..

[16]  D. Granoff,et al.  Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity , 2009, Clinical and Vaccine Immunology.

[17]  I. Williams,et al.  Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection , 2011, Retrovirology.

[18]  J. Donnelly,et al.  Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. , 2009, Vaccine.

[19]  A. Casadevall,et al.  Serum therapy revisited: animal models of infection and development of passive antibody therapy , 1994, Antimicrobial Agents and Chemotherapy.

[20]  D. Musher,et al.  Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia , 2000 .

[21]  A. Schlageter,et al.  Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide , 1990, Infection and immunity.

[22]  S. Akira,et al.  Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.

[23]  Y. Mikyas,et al.  Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody , 2004, Journal of Virology.

[24]  J. Skehel,et al.  An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.

[25]  J. Ravetch,et al.  Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.

[26]  M. Mazanec,et al.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies , 1995, Journal of virology.

[27]  G. Nybakken,et al.  West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody , 2006, Proceedings of the National Academy of Sciences.

[28]  S. Bacchetti,et al.  Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2 , 1982, Infection and immunity.

[29]  L. Luzzatto,et al.  Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. , 1998, Blood.

[30]  R. Heinzen,et al.  Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent , 2009, BMC Immunology.

[31]  J. Kappes,et al.  The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization , 2012, PloS one.

[32]  A. Capron,et al.  IgE antibody-mediated cytotoxicity of rat macrophages against microfilaria of Dipetalonema citeae in vitro. , 1980, Clinical and experimental immunology.

[33]  G. Parks,et al.  Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus. , 2008, Virology.

[34]  R. Discipio,et al.  The role of the complement anaphylatoxins in the recruitment of eosinophils. , 2007, International immunopharmacology.

[35]  M. McConnell,et al.  Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells , 2012, PloS one.

[36]  P. Ricciardi-Castagnoli,et al.  Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization , 1999, The Journal of experimental medicine.

[37]  B. Trus,et al.  Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution. , 1998, Journal of molecular biology.

[38]  Berzins,et al.  Antigenic Diversity of Plasmodium falciparum and Antibody‐Mediated Parasite Neutralization , 2000, Scandinavian journal of immunology.

[39]  D. Granoff,et al.  Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. , 1990, The Journal of infectious diseases.

[40]  M. Carroll,et al.  The complement system in regulation of adaptive immunity , 2004, Nature Immunology.

[41]  D. Salmon,et al.  Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum , 1986, Infection and immunity.

[42]  J. Kazura Host defense mechanisms against nematode parasites: destruction of newborn Trichinella spiralis larvae by human antibodies and granulocytes. , 1981, The Journal of infectious diseases.

[43]  R. Hernandez,et al.  Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal Antibody , 2008, Journal of Virology.

[44]  C. Mannella,et al.  The bactericidal effect of a complement-independent antibody is osmolytic and specific to Borrelia , 2009, Proceedings of the National Academy of Sciences.

[45]  J. Mak,et al.  Immune responses in human Brugia malayi infections: serum dependent cell-mediated destruction of infective larvae in vitro. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[46]  M. Reitz,et al.  Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro , 1995, Nature Medicine.

[47]  G. Marshall,et al.  The biology and future prospects of antivirulence therapies , 2008, Nature Reviews Microbiology.

[48]  P. Lydyard,et al.  Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[49]  N. Bourne,et al.  Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. , 2007, Journal of reproductive immunology.

[50]  N. Dimmock,et al.  Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event , 2001, Journal of Virology.

[51]  D. Burton,et al.  Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.

[52]  T. Out,et al.  Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. , 1994, The Journal of infectious diseases.

[53]  D. Metzger,et al.  Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections1 , 2001, The Journal of Immunology.

[54]  E. Daar,et al.  Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells , 2001, Journal of Virology.

[55]  G. Landucci,et al.  In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity. , 1998, Journal of immunological methods.

[56]  S. Bradley,et al.  Ontogeny of the immune response. IV. The role of antigen elimination in the true primary immune response in germfree, colostrum-deprived piglets. , 1967, Journal of immunology.

[57]  S. Rottem,et al.  Adhesion and biofilm formation of Mycoplasma pneumoniae on an abiotic surface , 2011, Archives of Microbiology.

[58]  B. Prasad,et al.  Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. , 2002, The Journal of clinical investigation.

[59]  R. Sauerwein,et al.  Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent , 1995, Infection and immunity.

[60]  D. Bout,et al.  Interaction between ToxoplasmaGondii and Enterocyte , 1999 .

[61]  S. Langermann,et al.  Development of a recombinant FimCH vaccine for urinary tract infections. , 2003, Advances in experimental medicine and biology.

[62]  D. Musher,et al.  Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  H. Lillehoj,et al.  Intestinal immune responses to coccidiosis. , 2000, Developmental and comparative immunology.

[64]  L. Lopalco,et al.  CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1 , 2000, The Journal of Immunology.

[65]  S. Zolla-Pazner,et al.  Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.

[66]  D. McFarlin,et al.  Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus , 1974, Nature.

[67]  Michael J. Davis,et al.  X-Linked Immunodeficient Mice Exhibit Enhanced Susceptibility to Cryptococcus neoformans Infection , 2013, mBio.

[68]  B. Benacerraf,et al.  Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.

[69]  L. James,et al.  Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) , 2010, Proceedings of the National Academy of Sciences.

[70]  M. Trudel,et al.  Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2 , 1996, Vaccine.

[71]  R. Rappuoli,et al.  Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. , 2003, The Journal of infectious diseases.

[72]  L. Nencioni,et al.  IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. , 1984, Journal of immunology.

[73]  M. Capron,et al.  Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides , 1990, Journal of clinical microbiology.

[74]  D. M. Lupan,et al.  Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide , 1990, Infection and immunity.

[75]  A. Bohbot,et al.  Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. , 2004, Journal of immunology.

[76]  Y. Yuthavong,et al.  Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. , 1990, Blood cells.

[77]  T. Burkot,et al.  Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum , 1983, The Journal of experimental medicine.

[78]  M. Wong,et al.  FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. , 2003, Immunology and cell biology.

[79]  D. R. Anderson,et al.  Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. , 1997, Biochemical Society transactions.

[80]  J. V. D. van de Winkel,et al.  A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. , 1991, Journal of immunology.

[81]  M. Dziegiel,et al.  A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII1 , 2007, The Journal of Immunology.

[82]  A. Celada,et al.  Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. , 1982, Clinical and experimental immunology.

[83]  R. Sindhu,et al.  Antibody-dependent cell-mediated effects in bancroftian filariasis. , 1981, Immunology.

[84]  M. Sliwkowski,et al.  Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). , 1999, Seminars in oncology.

[85]  L. Rönnblom,et al.  Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA. , 2006, Arthritis and rheumatism.

[86]  P. Auewarakul,et al.  Identification of prohibitin as a Chikungunya virus receptor protein , 2012, Journal of medical virology.

[87]  M. Ouattara,et al.  Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. , 1993, The Journal of infectious diseases.

[88]  S. Wahl,et al.  Polyreactive Antibodies Plus Complement Enhance the Phagocytosis of Cells Made Apoptotic by UV-Light or HIV , 2013, Scientific Reports.

[89]  A. Shiratsuchi,et al.  Evidence for Phagocytosis of Influenza Virus-Infected, Apoptotic Cells by Neutrophils and Macrophages in Mice1 , 2007, The Journal of Immunology.

[90]  N. Dimmock,et al.  Neutralization of animal virus infectivity by antibody , 2007, Archives of Virology.

[91]  Sakae Tanaka,et al.  Fcγ receptor signaling in primary human microglia: differential roles of PI‐3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction , 2004, Journal of leukocyte biology.

[92]  P. Brioen,et al.  Neutralization of poliovirus by antibody-mediated polymerization. , 1983, Virology.

[93]  J. Mcghee,et al.  Function of anti-Streptococcus mutans antibodies: anti-ribosomal antibodies inhibit acid production, growth, and glucose phosphotransferase activity , 1984, Infection and Immunity.

[94]  D. Mosser,et al.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. , 2010, Immunology letters.

[95]  M. Dziegiel,et al.  A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. , 2007, Journal of immunology.

[96]  J. Ravetch,et al.  Fcgamma receptors as regulators of immune responses. , 2008, Nature reviews. Immunology.

[97]  A. Capron,et al.  A new function for platelets: IgE-dependent killing of schistosomes , 1983, Nature.

[98]  A. Cravioto,et al.  Antigen Detection in EnteropathogenicEscherichia coli Using Secretory Immunoglobulin A Antibodies Isolated from Human Breast Milk , 2000, Infection and Immunity.

[99]  J. Dankert,et al.  Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  M. Perkins,et al.  Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes. , 1988, Journal of immunology.

[101]  A. Ferrante,et al.  The role of complement, antibody, and tumor necrosis factor alpha in the killing of Plasmodium falciparum by the monocytic cell line THP-1 , 1997, Infection and immunity.

[102]  T. Bergström,et al.  Glycoprotein G of Herpes Simplex Virus 2 as a Novel Vaccine Antigen for Immunity to Genital and Neurological Disease , 2012, Journal of Virology.

[103]  M. Diamond,et al.  Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. , 2003, Viral immunology.

[104]  T. Cate,et al.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement , 1980, Journal of clinical microbiology.

[105]  P. Brandtzaeg Induction of secretory immunity and memory at mucosal surfaces. , 2007, Vaccine.

[106]  S. Levy,et al.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity , 2003, Nature Medicine.

[107]  G. Pietersz,et al.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond , 2012, Nature Reviews Drug Discovery.

[108]  Subhash G. Vasudevan,et al.  Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection , 2011, Proceedings of the National Academy of Sciences.

[109]  L. Nencioni,et al.  Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA , 1983, Nature.

[110]  M. Pichichero,et al.  Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. , 2012, Vaccine.

[111]  D. Fremont,et al.  Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc-γ Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells , 2007, Journal of Virology.

[112]  J. V. D. van de Winkel,et al.  Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. , 1999, The Journal of infectious diseases.

[113]  S. Zolla-Pazner,et al.  Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells , 2006, Journal of Virology.

[114]  F. Mooi,et al.  Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. , 2001, The Journal of infectious diseases.

[115]  D. Forthal,et al.  Fc receptor-mediated antiviral antibodies , 2009, Current opinion in HIV and AIDS.

[116]  Kevin Marsh,et al.  Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. , 2012, The Journal of clinical investigation.

[117]  Y. Rikihisa,et al.  Two Monoclonal Antibodies with Defined Epitopes of P44 Major Surface Proteins Neutralize Anaplasma phagocytophilum by Distinct Mechanisms , 2006, Infection and Immunity.

[118]  I. Khan,et al.  Toxoplasma gondii: a monoclonal antibody that inhibits intracellular replication. , 1994, Experimental parasitology.

[119]  A. Camilli,et al.  Mucosal Immunization with Vibrio cholerae Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility , 2010, Infection and Immunity.

[120]  R. M. Vejborg,et al.  Prevention of bacterial adhesion , 2010, Applied Microbiology and Biotechnology.

[121]  A. Casadevall,et al.  Mechanism for the Isotype Dependence of Antibody-Mediated Toxicity in Cryptococcus neoformans-Infected Mice1 , 2000, The Journal of Immunology.

[122]  L. Eckmann Mucosal defences against Giardia , 2003, Parasite immunology.

[123]  J. F. Albright,et al.  Antibody‐facilitated macrophage killing of Trypanosoma musculi is an extracellular process as studied in several variations Of an in vitro analytical system , 1994, Journal of leukocyte biology.

[124]  W. Otieno,et al.  Reduced Immune Complex Binding Capacity and Increased Complement Susceptibility of Red Cells from Children with Severe Malaria-Associated Anemia , 2008, Molecular medicine.

[125]  H. Rotman,et al.  Immunity to a challenge infection of Strongyloides stercoralis third‐stage larvae in the jird , 1995, Parasite immunology (Print).

[126]  M. Walport Complement. First of two parts. , 2001, The New England journal of medicine.

[127]  L. Joosten,et al.  Complement plays a central role in Candida albicans‐induced cytokine production by human PBMCs , 2012, European journal of immunology.

[128]  C. Newbold,et al.  Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence. , 1991, Immunology letters.

[129]  R. Macdermott,et al.  Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera , 1979, The Journal of experimental medicine.

[130]  H. Greenberg,et al.  Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune Exclusion , 2006, Journal of Virology.

[131]  J. Takala,et al.  A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[132]  T. Mayadas,et al.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. , 2008, Immunity.

[133]  F. Lunel,et al.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of Experimental Medicine.

[134]  R Möllby,et al.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. , 2000, The Journal of infectious diseases.

[135]  T. Pierson,et al.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection , 2008, Expert Reviews in Molecular Medicine.

[136]  Minoru Fukuda,et al.  Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis , 2008, Nature Medicine.

[137]  K. McCullough,et al.  Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody. , 1987, Immunology.

[138]  I. Goldstein,et al.  Characterization of polymorphic forms of Fc receptor III on human neutrophils. , 1989, The Journal of clinical investigation.

[139]  T. Hope,et al.  New paradigms for functional HIV-specific nonneutralizing antibodies. , 2013, Current opinion in HIV and AIDS.

[140]  J. Michl,et al.  Neutrophils do not bind to or phagocytize human immune complexes formed with influenza virus. , 1993, Blood.

[141]  D. Golenbock,et al.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. , 2005, The Journal of clinical investigation.

[142]  R. A. Nelson The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. , 1953, Science.

[143]  F. Ennis,et al.  Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies , 2011, Journal of Virology.

[144]  Y. Xu,et al.  Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. , 2000, Vaccine.

[145]  Arturo Casadevall,et al.  CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. , 2002, Immunity.

[146]  Samir N. Patel,et al.  C5 deficiency and C5a or C5aR blockade protects against cerebral malaria , 2008, The Journal of experimental medicine.

[147]  C. Dupont,et al.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. , 1998, Immunity.

[148]  C. Juárez,et al.  Relevance of genetically determined host factors to the prognosis of meningococcal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[149]  A. Holder,et al.  Immunization against blood-stage rodent malaria using purified parasite antigens , 1981, Nature.

[150]  P. Lydyard,et al.  Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis , 2000 .

[151]  A. A. Reeder,et al.  Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella. , 1980, Journal of immunology.

[152]  S. Alonso,et al.  Release of Arachidonic Acid by Stimulation of Opsonic Receptors in Human Monocytes , 2003, Journal of Biological Chemistry.

[153]  R. Tesh,et al.  Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms , 2011, Journal of Virology.

[154]  Shibo Jiang,et al.  Binding of the 2F5 Monoclonal Antibody to Native and Fusion-Intermediate Forms of Human Immunodeficiency Virus Type 1 gp41: Implications for Fusion-Inducing Conformational Changes , 2004, Journal of Virology.

[155]  H. Farrell,et al.  Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. , 1991, The Journal of general virology.

[156]  S. Ram,et al.  Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy , 2010, Clinical Microbiology Reviews.

[157]  L. Pirofski,et al.  A Serotype 3 Pneumococcal Capsular Polysaccharide-Specific Monoclonal Antibody Requires Fcγ Receptor III and Macrophages To Mediate Protection against Pneumococcal Pneumonia in Mice , 2012, Infection and Immunity.

[158]  S. Costantino,et al.  Immune killing of newborn Trichinella larvae by human leucocytes , 1993, Parasite immunology.

[159]  V. Vedham,et al.  Anti-Peptidoglycan Antibodies and Fcγ Receptors Are the Key Mediators of Inflammation in Gram-Positive Sepsis , 2012, The Journal of Immunology.

[160]  J. Köhl,et al.  C5a Initiates the Inflammatory Cascade in Immune Complex Peritonitis1 , 2004, The Journal of Immunology.

[161]  P. Stewart,et al.  Recent structural solutions for antibody neutralization of viruses. , 1997, Trends in microbiology.

[162]  H. Snippe,et al.  The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. , 1986, Immunology.

[163]  H. Fujisawa Neutrophils Play an Essential Role in Cooperation with Antibody in both Protection against and Recovery from Pulmonary Infection with Influenza Virus in Mice , 2008, Journal of Virology.

[164]  W. Dominic Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA.Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.Mol Med. 2008 Mar-Apr;14(3-4):89-97 , 2008 .

[165]  P. Bruhns,et al.  Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.

[166]  A. Capron,et al.  High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.

[167]  M. Horwitz,et al.  Interaction of the legionnaires' disease bacterium (legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclearleukocytes, antibody, and complement , 1981, The Journal of experimental medicine.

[168]  R. Lawrence Immunity to filarial nematodes. , 2001, Veterinary parasitology.

[169]  D. Kabat,et al.  Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry , 2012, Proceedings of the National Academy of Sciences.

[170]  J. Burnie,et al.  Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. , 2005, Diagnostic microbiology and infectious disease.

[171]  Y. Ishii,et al.  Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. , 2010, Virology.

[172]  A. Casadevall,et al.  Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance , 2006, Cellular microbiology.

[173]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[174]  F. Galdiero,et al.  Cytotoxic antibody dependent cells in mice experimentally infected with Brucella abortus. , 1985, Microbiologica.

[175]  A. Lux,et al.  Impact of differential glycosylation on IgG activity. , 2011, Advances in experimental medicine and biology.

[176]  D. Filman,et al.  Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope , 1995, Nature Structural Biology.

[177]  A. Casadevall,et al.  Review Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases , 2022 .

[178]  C. Juárez,et al.  Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. , 2002, The American journal of medicine.

[179]  T. Hartung,et al.  Internalization and Coreceptor Expression Are Critical for TLR2-Mediated Recognition of Lipoteichoic Acid in Human Peripheral Blood , 2010, The Journal of Immunology.

[180]  A. Capron,et al.  Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies , 1986, The Journal of experimental medicine.

[181]  D. Broide,et al.  A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. , 1999, Journal of immunology.

[182]  T. Out,et al.  The role of Fcγ receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement‐deficient individuals , 2000, Clinical and experimental immunology.

[183]  Huimin Yan,et al.  Multiple Functions of Immunoglobulin A in Mucosal Defense against Viruses: an In Vitro Measles Virus Model , 2002, Journal of Virology.

[184]  E. G. Westaway,et al.  A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.

[185]  S. Khusmith,et al.  Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum , 1983, Infection and immunity.

[186]  T. Takai Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.

[187]  N. Stollman,et al.  Molecular basis for a polymorphism involving Fc receptor II on human monocytes. , 1989, Journal of immunology.

[188]  R. S. MacGill,et al.  Complement Is Essential for Protection by an IgM and an IgG3 Monoclonal Antibody Against Experimental, Hematogenously Disseminated Candidiasis1 , 2001, Journal of Immunology.

[189]  Kenneth G. C. Smith,et al.  FcγRIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis , 2004, The Journal of experimental medicine.

[190]  C. García-Rodríguez,et al.  Activation of monocytic cells through Fc gamma receptors induces the expression of macrophage-inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES. , 2002, Journal of immunology.

[191]  T. Clark,et al.  Passive immunization of channel catfish (Ictalurus punctatus) against the ciliated protozoan parasite Ichthyophthirius multifiliis by use of murine monoclonal antibodies , 1996, Infection and immunity.

[192]  D. Granoff Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. , 2009, Vaccine.

[193]  John P. Moore,et al.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? , 2012, AIDS research and human retroviruses.

[194]  H. Greenberg,et al.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture , 1991, Journal of virology.

[195]  A. Alonso,et al.  The expression of cytokine‐induced neutrophil chemoattractants (CINC‐1 and CINC‐2) in rat peritoneal macrophages is triggered by Fcγ receptor activation: Study of the signaling mechanism , 1996, European journal of immunology.

[196]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[197]  P. Kaye,et al.  Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses , 2003, Nature Medicine.

[198]  R. Sandeman,et al.  Antibody‐dependent cell‐mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates , 2001, Parasite immunology.

[199]  K. Yoshino,et al.  STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT. , 1965, Virology.

[200]  Johannes S. Gach,et al.  Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12 , 2010, The Journal of Immunology.

[201]  G. Landucci,et al.  Interactions between Natural Killer Cells and Antibody Fc Result in Enhanced Antibody Neutralization of Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.

[202]  J. L. Nieva,et al.  Recognition and Blocking of HIV-1 gp41 Pre-transmembrane Sequence by Monoclonal 4E10 Antibody in a Raft-like Membrane Environment* , 2006, Journal of Biological Chemistry.

[203]  M. Carroll,et al.  Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior Immunity , 2007, Journal of Virology.

[204]  A. Thomas,et al.  Relationship between poliovirus neutralization and aggregation , 1986, Journal of virology.

[205]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[206]  A. Nisalak,et al.  Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2 , 1995, Journal of medical virology.

[207]  M. Kazanji,et al.  In vitro interactions between murine neutrophils and Eimeria falciformis sporozoites. , 1992, Research in immunology.

[208]  J. Jacobson,et al.  Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection. , 2010, The Journal of antimicrobial chemotherapy.

[209]  L. Pirofski,et al.  Antifungal Activity of a Human Antiglucuronoxylomannan Antibody , 1998, Clinical Diagnostic Laboratory Immunology.

[210]  T. Out,et al.  Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. , 1994, Immunology.

[211]  J. Kinet,et al.  Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria , 2011, The Journal of experimental medicine.

[212]  L. Schlesinger,et al.  Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. , 1994, Journal of immunology.

[213]  A. Capron Schistosomiasis: forty years' war on the worm. , 1998, Parasitology Today.

[214]  G. Blobel,et al.  Site-specific antibodies against the PrlA (secY) protein of Escherichia coli inhibit protein export by interfering with plasma membrane binding of preproteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[215]  J. Chen,et al.  Ligation of Fc gamma receptor IIB enhances levels of antiviral cytokine in response to PRRSV infection in vitro. , 2012, Veterinary microbiology.

[216]  O. Ogunremi,et al.  CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide. , 2006, Microbes and infection.

[217]  M. Dierich,et al.  Complement-HIV interactions during all steps of viral pathogenesis. , 2008, Vaccine.

[218]  Deming Zhao,et al.  Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport , 2011, Proceedings of the National Academy of Sciences.

[219]  P. Hogarth,et al.  Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction , 1993, The Journal of experimental medicine.

[220]  S. Iida,et al.  A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques , 2012, Journal of Virology.

[221]  W. Levinson,et al.  Complement components required for virus neutralization by early immunoglobulin antibody. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[222]  Q. Sattentau,et al.  Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.

[223]  D. Negrão-Corrêa,et al.  Importance of immunoglobulin E (IgE) in the protective mechanism against gastrointestinal nematode infection: looking at the intestinal mucosae. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.

[224]  Yuxian He,et al.  The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus , 2012, PloS one.

[225]  T. Kurosaki,et al.  SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. , 1999, Immunity.

[226]  E Kohli,et al.  Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view. , 2001, Journal of molecular biology.

[227]  R. Lamb,et al.  Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. , 1995, Virology.

[228]  M. Tanner,et al.  Studies on Dipetalonema viteae (Filarioidea) 3. Antibody-dependent cell-mediated destruction of microfilariae in vivo. , 1979, Tropenmedizin und Parasitologie.

[229]  S. Jancar,et al.  Immune complex-mediated tissue injury: a multistep paradigm. , 2005, Trends in immunology.

[230]  T. Kurosaki,et al.  SHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis , 1999 .

[231]  L. Lopalco,et al.  Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy , 2005, Journal of Virology.

[232]  M. Viveen,et al.  Serum Antibodies Critically Affect Virus-Specific CD4+/CD8+ T Cell Balance during Respiratory Syncytial Virus Infections , 2010, The Journal of Immunology.

[233]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[234]  A. Casadevall,et al.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. , 2010, The Journal of clinical investigation.

[235]  T. Out,et al.  Fcã Receptor Iia (Cd32) Polymorphism In Fulminant Meningococcal Septic , 1994 .

[236]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[237]  C. Janeway,et al.  The complement system and innate immunity , 2001 .

[238]  G. Landucci,et al.  Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells , 2006, Journal of Virology.

[239]  M. Wong,et al.  FcγRIIA polymorphisms in Streptococcus pneumoniae infection , 2003 .

[240]  C. Kaetzel,et al.  Intracellular neutralization of virus by immunoglobulin A antibodies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[241]  T. Theander,et al.  Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria* , 2012, The Journal of Biological Chemistry.

[242]  J. Bunn,et al.  Antibodies in Action: Role of Human Opsonins in Killing Salmonella enterica Serovar Typhi , 2011, Infection and Immunity.

[243]  I. Bekeredjian-Ding,et al.  Staphylococcus aureus-Induced Plasmacytoid Dendritic Cell Activation Is Based on an IgG-Mediated Memory Response1 , 2008, The Journal of Immunology.

[244]  R. Carter,et al.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230 , 1997, Infection and immunity.

[245]  B. Eikmanns,et al.  The Fibrinogen Receptor FbsA Promotes Adherence of Streptococcus agalactiae to Human Epithelial Cells , 2004, Infection and Immunity.

[246]  B. Perussia,et al.  Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions , 1989, The Journal of experimental medicine.

[247]  J. Burnie,et al.  Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90 , 2003, Antimicrobial Agents and Chemotherapy.

[248]  R. Webster,et al.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. , 1967, Journal of immunology.

[249]  G. Leroux-Roels,et al.  Anti‐CD81 antibodies can prevent a hepatitis C virus infection in vivo , 2008, Hepatology.

[250]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.

[251]  L. Lei,et al.  Matrix Protein-Specific IgA Antibody Inhibits Measles Virus Replication by Intracellular Neutralization , 2011, Journal of Virology.

[252]  H. C. Scott,et al.  Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. , 1988, Immunology.

[253]  Z. Bánki,et al.  Emerging role for complement in HIV infection. , 2011, Current opinion in HIV and AIDS.

[254]  C. Janeway,et al.  The destruction of antibody-coated pathogens via Fc receptors , 2001 .

[255]  A. Bohbot,et al.  Involvement of FcγR I (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified from Infected Patients in Cultured Monocyte-Derived Macrophages1 , 2004, The Journal of Immunology.

[256]  Nancy Haigwood,et al.  Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma , 1999, Nature Medicine.

[257]  A. Casadevall,et al.  Murine IgG1 and IgG3 Isotype Switch Variants Promote Phagocytosis of Cryptococcus neoformans through Different Receptors , 2009, The Journal of Immunology.

[258]  P. Arese,et al.  Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. , 2004, Blood.

[259]  M R Clark,et al.  Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. , 1989, The Journal of clinical investigation.

[260]  A. Jegerlehner,et al.  Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity , 2004, The Journal of Immunology.

[261]  C. Cuffini,et al.  Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells. , 2000, Viral immunology.

[262]  C. García-Rodríguez,et al.  Activation of Monocytic Cells Through Fcγ Receptors Induces the Expression of Macrophage-Inflammatory Protein (MIP)-1α, MIP-1β, and RANTES1 , 2002, The Journal of Immunology.

[263]  H. Lyerly,et al.  Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. , 1987, AIDS research and human retroviruses.

[264]  T. Horii,et al.  Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). , 1998, Vaccine.

[265]  A. Glenny,et al.  Duration of Passive Immunity , 1922, Journal of Hygiene.

[266]  J. Schmitz,et al.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59. , 1995, The Journal of clinical investigation.

[267]  C. Mold,et al.  Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fcγ Receptors1 , 2002, The Journal of Immunology.

[268]  P. D. Smith,et al.  Human host response to Giardia lamblia. II. Antibody-dependent killing in vitro. , 1983, Cellular immunology.

[269]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[270]  A. Halstensen,et al.  FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway , 2003, Epidemiology and Infection.

[271]  R. Chandrashekar,et al.  Characterization of a monoclonal antibody against infective larvae of Brugia malayi. , 1988, Immunology.

[272]  E. Unanue,et al.  Intracellular antibody neutralizes Listeria growth. , 2001, Immunity.

[273]  Wutian Wu,et al.  Human γδ T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis1 , 2009, The Journal of Immunology.

[274]  A. Siddiqui,et al.  Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni. , 2012, Vaccine.

[275]  Y. Rikihisa,et al.  Presence of parasite antigen on the surface of P388D1 cells infected with Ehrlichia risticii , 1992, Infection and immunity.